News

In Covid-19 pandemic budget, vaccines & healthcare get government attention

With substantial increase in the allocation for healthcare (137 % more) and special funds for Covid-19 vaccination drive, the Budget for 2021-22 presented by the Finance Minister Mrs Nirmala Sitharaman on February 1 has given a boost to many segments of the biotechnology industry

Bharat Biotech signs agreement with Precisa Medicamentos regarding supplies of ‘COVAXIN™’ to Brazil

Hyderabad, India, January 12, 2020: Bharat Biotech announced that it has signed an agreement with Precisa Medicamentos for the supplies of COVAXIN™ to Brazil.

Jan 13, 2021

By : Team ABLE

Bharat Biotech Successfully Ships out COVAXIN™ to 11 cities, donates 16.5 Lakh doses to the Government

Hyderabad, India, January 13, 2021: Bharat Biotech has announced the successful air-shipment of COVAXIN™, to 11 cities in India in the early hours of Wednesday. Bharat Biotech has also donated 16.5 Lakh doses to the Government of India.

Jan 13, 2021

By : Team ABLE

An emotional moment for the team at The Serum Institute of India

An emotional moment for the team at The Serum Institute of India as the first shipments of COVISHIELD finally leave for multiple locations across India', tweets SII CEO Adar Poonawalla

Jan 13, 2021

By : The Hindu

Bharat Biotech’s ‘COVAXIN™’ Emergency Use Authorization approval by DCGI-CDSCO, MoH&FW, a significant landmark in India’s Scientific Discovery, and Scientists Capability

Dr. Krishna Ella said “The approval of COVAXIN™ for emergency use is a giant leap for Innovation and novel product development in India. It is a proud moment for the nation and a great milestone in India’s scientific capability, a kickstart to the innovation ecosystem in India. While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the most. COVAXIN™ has generated excellent safety data with robust immune responses to multiple viral proteins that persist.”

Jan 03, 2021

By : Team ABLE